Covers changes across profit lines in which FY2023 saw revenue growth, higher operating profit and higher ordinary profit but lower net income due to impairment losses on investment securities and provisions for losses related to the Antimonopoly Act, while FY2026 is expected to see lower operating profit and ordinary profit despite revenue growth, but higher net income due to gains on the sale of shares and other factors.